Disclosure statements regarding hormonal treatment of prostate cancer.
D000726:Androgen Antagonists / Q000627:therapeutic use; D016265:Conflict of Interest; D005485:Flutamide / Q000627:therapeutic use; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000628:therapy*; D012109:Research Support as Topic
D000726:Androgen Antagonists; D005485:Flutamide